SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-005967
Filing Date
2021-05-05
Accepted
2021-05-05 17:26:52
Documents
58
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20210331x10q.htm   iXBRL 10-Q 1568586
2 EX-10.1 xncr-20210331xex10d1.htm EX-10.1 73104
3 EX-31.1 xncr-20210331xex31d1.htm EX-31.1 17347
4 EX-31.2 xncr-20210331xex31d2.htm EX-31.2 17436
5 EX-32.1 xncr-20210331xex32d1.htm EX-32.1 10080
  Complete submission text file 0001558370-21-005967.txt   7162300

Data Files

Seq Description Document Type Size
6 EX-101.SCH xncr-20210331.xsd EX-101.SCH 39737
7 EX-101.CAL xncr-20210331_cal.xml EX-101.CAL 51979
8 EX-101.DEF xncr-20210331_def.xml EX-101.DEF 150106
9 EX-101.LAB xncr-20210331_lab.xml EX-101.LAB 427823
10 EX-101.PRE xncr-20210331_pre.xml EX-101.PRE 301301
11 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20210331x10q_htm.xml XML 1478392
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 21894698
SIC: 2834 Pharmaceutical Preparations